Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor

R. K. Rao, H. H. Chang, S. Levenson, Frank Porreca, P. M. Brannon, Thomas P Davis, O. Koldovsky

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Gastric secretions were studied in rats by pyloric ligation in vivo. The effects of epidermal growth factor (EGF) administered s.c. on gastric secretion were evaluated at different stages of development (8, 14, 20 and 30 postnatal days). The rates of fluid, protein and acid outputs were very low in developing rats but increased in maturing rats. The rate of acid output in 8-day-old rats (3.83 ± 1.16) was not different from that in 14-day-old rats (4.84 ± 0.99), whereas the rate of acid output in 20-day-old rats was 11- fold greater than that in 14-day-old rats, and it was 21-fold greater in 30- day-old rats. Subcutaneous administration of 30 μg/kg b.wt. of EGF significantly suppressed the gastric secretion of fluid, protein and acid in 20- and 30-day-old rats. In 30-day-old rats, acid output was 85% lower at 1 hr after EGF administration and in 20-day-old rats it was 85% lower at 2 hr and 50% lower at 3 hr. Interestingly, EGF had no effect on basal gastric secretions in 8- and 14-day-old rats; EGF also had no effect on the gastric acid output that was stimulated by pentagastrin administration in 14-day-old rats. In 20-day-old rats, inhibitory effects of EGF lasted for 3 hr before gastric secretions rebounded to normal levels, but inhibition lasted for only 1 hr in 30-day-old rats. EGF was nearly 15-fold more potent in 20-day-old rats than in 30-day-old; the A50 (95% C.L.) values for EGF in 20- and 30- day-old rats were 7.5 (4.6-12.4) and 117.3 (77.2-168.5) μg/kg b.wt., respectively. EGF up to 950 μg/kg b.wt. showed no effect in 8- and 14-day- old rats. EGF receptors in gastric mucosal membranes, as analyzed by radioligand binding showed no age-related differences in their K(d) values, whereas maximum binding values in membranes prepared from 20-day-old rats was significantly greater than those in membranes prepared from 8-, 14- or 30- day-old rats. These results demonstrate ontogenic differences in the potency and efficacy of EGF in inhibiting gastric secretions in rats.

Original languageEnglish (US)
Pages (from-to)647-654
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume266
Issue number2
StatePublished - 1993

Fingerprint

Gastric Acid
Epidermal Growth Factor
Stomach
Acids
Membranes
Fluids and Secretions
Pentagastrin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor. / Rao, R. K.; Chang, H. H.; Levenson, S.; Porreca, Frank; Brannon, P. M.; Davis, Thomas P; Koldovsky, O.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 266, No. 2, 1993, p. 647-654.

Research output: Contribution to journalArticle

Rao, R. K. ; Chang, H. H. ; Levenson, S. ; Porreca, Frank ; Brannon, P. M. ; Davis, Thomas P ; Koldovsky, O. / Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor. In: Journal of Pharmacology and Experimental Therapeutics. 1993 ; Vol. 266, No. 2. pp. 647-654.
@article{985f1bec232f4a4188350b639750cc1c,
title = "Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor",
abstract = "Gastric secretions were studied in rats by pyloric ligation in vivo. The effects of epidermal growth factor (EGF) administered s.c. on gastric secretion were evaluated at different stages of development (8, 14, 20 and 30 postnatal days). The rates of fluid, protein and acid outputs were very low in developing rats but increased in maturing rats. The rate of acid output in 8-day-old rats (3.83 ± 1.16) was not different from that in 14-day-old rats (4.84 ± 0.99), whereas the rate of acid output in 20-day-old rats was 11- fold greater than that in 14-day-old rats, and it was 21-fold greater in 30- day-old rats. Subcutaneous administration of 30 μg/kg b.wt. of EGF significantly suppressed the gastric secretion of fluid, protein and acid in 20- and 30-day-old rats. In 30-day-old rats, acid output was 85{\%} lower at 1 hr after EGF administration and in 20-day-old rats it was 85{\%} lower at 2 hr and 50{\%} lower at 3 hr. Interestingly, EGF had no effect on basal gastric secretions in 8- and 14-day-old rats; EGF also had no effect on the gastric acid output that was stimulated by pentagastrin administration in 14-day-old rats. In 20-day-old rats, inhibitory effects of EGF lasted for 3 hr before gastric secretions rebounded to normal levels, but inhibition lasted for only 1 hr in 30-day-old rats. EGF was nearly 15-fold more potent in 20-day-old rats than in 30-day-old; the A50 (95{\%} C.L.) values for EGF in 20- and 30- day-old rats were 7.5 (4.6-12.4) and 117.3 (77.2-168.5) μg/kg b.wt., respectively. EGF up to 950 μg/kg b.wt. showed no effect in 8- and 14-day- old rats. EGF receptors in gastric mucosal membranes, as analyzed by radioligand binding showed no age-related differences in their K(d) values, whereas maximum binding values in membranes prepared from 20-day-old rats was significantly greater than those in membranes prepared from 8-, 14- or 30- day-old rats. These results demonstrate ontogenic differences in the potency and efficacy of EGF in inhibiting gastric secretions in rats.",
author = "Rao, {R. K.} and Chang, {H. H.} and S. Levenson and Frank Porreca and Brannon, {P. M.} and Davis, {Thomas P} and O. Koldovsky",
year = "1993",
language = "English (US)",
volume = "266",
pages = "647--654",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor

AU - Rao, R. K.

AU - Chang, H. H.

AU - Levenson, S.

AU - Porreca, Frank

AU - Brannon, P. M.

AU - Davis, Thomas P

AU - Koldovsky, O.

PY - 1993

Y1 - 1993

N2 - Gastric secretions were studied in rats by pyloric ligation in vivo. The effects of epidermal growth factor (EGF) administered s.c. on gastric secretion were evaluated at different stages of development (8, 14, 20 and 30 postnatal days). The rates of fluid, protein and acid outputs were very low in developing rats but increased in maturing rats. The rate of acid output in 8-day-old rats (3.83 ± 1.16) was not different from that in 14-day-old rats (4.84 ± 0.99), whereas the rate of acid output in 20-day-old rats was 11- fold greater than that in 14-day-old rats, and it was 21-fold greater in 30- day-old rats. Subcutaneous administration of 30 μg/kg b.wt. of EGF significantly suppressed the gastric secretion of fluid, protein and acid in 20- and 30-day-old rats. In 30-day-old rats, acid output was 85% lower at 1 hr after EGF administration and in 20-day-old rats it was 85% lower at 2 hr and 50% lower at 3 hr. Interestingly, EGF had no effect on basal gastric secretions in 8- and 14-day-old rats; EGF also had no effect on the gastric acid output that was stimulated by pentagastrin administration in 14-day-old rats. In 20-day-old rats, inhibitory effects of EGF lasted for 3 hr before gastric secretions rebounded to normal levels, but inhibition lasted for only 1 hr in 30-day-old rats. EGF was nearly 15-fold more potent in 20-day-old rats than in 30-day-old; the A50 (95% C.L.) values for EGF in 20- and 30- day-old rats were 7.5 (4.6-12.4) and 117.3 (77.2-168.5) μg/kg b.wt., respectively. EGF up to 950 μg/kg b.wt. showed no effect in 8- and 14-day- old rats. EGF receptors in gastric mucosal membranes, as analyzed by radioligand binding showed no age-related differences in their K(d) values, whereas maximum binding values in membranes prepared from 20-day-old rats was significantly greater than those in membranes prepared from 8-, 14- or 30- day-old rats. These results demonstrate ontogenic differences in the potency and efficacy of EGF in inhibiting gastric secretions in rats.

AB - Gastric secretions were studied in rats by pyloric ligation in vivo. The effects of epidermal growth factor (EGF) administered s.c. on gastric secretion were evaluated at different stages of development (8, 14, 20 and 30 postnatal days). The rates of fluid, protein and acid outputs were very low in developing rats but increased in maturing rats. The rate of acid output in 8-day-old rats (3.83 ± 1.16) was not different from that in 14-day-old rats (4.84 ± 0.99), whereas the rate of acid output in 20-day-old rats was 11- fold greater than that in 14-day-old rats, and it was 21-fold greater in 30- day-old rats. Subcutaneous administration of 30 μg/kg b.wt. of EGF significantly suppressed the gastric secretion of fluid, protein and acid in 20- and 30-day-old rats. In 30-day-old rats, acid output was 85% lower at 1 hr after EGF administration and in 20-day-old rats it was 85% lower at 2 hr and 50% lower at 3 hr. Interestingly, EGF had no effect on basal gastric secretions in 8- and 14-day-old rats; EGF also had no effect on the gastric acid output that was stimulated by pentagastrin administration in 14-day-old rats. In 20-day-old rats, inhibitory effects of EGF lasted for 3 hr before gastric secretions rebounded to normal levels, but inhibition lasted for only 1 hr in 30-day-old rats. EGF was nearly 15-fold more potent in 20-day-old rats than in 30-day-old; the A50 (95% C.L.) values for EGF in 20- and 30- day-old rats were 7.5 (4.6-12.4) and 117.3 (77.2-168.5) μg/kg b.wt., respectively. EGF up to 950 μg/kg b.wt. showed no effect in 8- and 14-day- old rats. EGF receptors in gastric mucosal membranes, as analyzed by radioligand binding showed no age-related differences in their K(d) values, whereas maximum binding values in membranes prepared from 20-day-old rats was significantly greater than those in membranes prepared from 8-, 14- or 30- day-old rats. These results demonstrate ontogenic differences in the potency and efficacy of EGF in inhibiting gastric secretions in rats.

UR - http://www.scopus.com/inward/record.url?scp=0027442004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027442004&partnerID=8YFLogxK

M3 - Article

C2 - 8355198

AN - SCOPUS:0027442004

VL - 266

SP - 647

EP - 654

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -